Premium
Urinary growth hormone excretion in post‐menarcheal adolescent girls with type 1 diabetes
Author(s) -
Åman J,
Kroon M,
Jones I,
Segnestam K,
Snellman K
Publication year - 1998
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1998.tb00966.x
Subject(s) - igfbp3 , endocrinology , medicine , immunoradiometric assay , urinary system , urine , hormone , growth hormone , diabetes mellitus , excretion , growth factor , radioimmunoassay , receptor
The aim of the present study was to compare measurements of urinary growth hormone (GH), serum insulinlike growth factor I (IGF‐I) and IGF binding protein 3 (IGFBP3) between two groups of post‐menarcheal girls, 13–18 y of age, one comprising 64 type 1 diabetic patients and the other 64 healthy girls matched for age and stage of puberty. GH was determined on two occasions in nocturnal urine samples by using a modification of an immunoradiometric method for serum. Significantly higher urinary GH concentrations but lower IGF‐I and IGFBP3 levels were found in diabetic girls than in controls ( p < 0:001). A significant correlation was found between urinary GH concentrations and the daily dose of insulin (U kg −1 ) ( r = 0:426, p = 0:003). Urinary GH concentrations were also significantly related to HbA1c ( r = 0:380, p = 0:003). In conclusion, disturbances of the GH‐IGF‐I axis may be evaluated by the use of non‐invasive urinary GH measurements, which is a simple alternative to frequent sampling of serum GH. Increased GH secretion seems to be related to a great need for insulin and poor metabolic control. More knowledge about underlying causal factors in the disturbed GH‐IGF‐I axis is required.